• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髋关节保髋治疗还是全髋关节置换术?一项在中国影响股骨头坏死患者行关节置换术决策因素的回顾性病例对照研究。

Hip Preservation or Total Hip Arthroplasty? A Retrospective Case-Control Study of Factors Influencing Arthroplasty Decision-Making for Patients with Osteonecrosis of the Femoral Head in China.

机构信息

The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.

Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.

出版信息

Orthop Surg. 2023 Mar;15(3):731-739. doi: 10.1111/os.13639. Epub 2023 Jan 10.

DOI:10.1111/os.13639
PMID:36625784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977578/
Abstract

OBJECTIVE

At present, there is no consensus or guidance on indications for osteonecrosis of the femoral head (ONFH) patients to receive hip arthroplasty (THA) treatment. This study aims to explore the factors that influence the decision-making for THA in patients with ONFH, and to provide references for clinical decision for ONFH patients to be indicated for THA or hip preservation.

METHODS

This retrospective case-control study involved data for ONFH patients from July 2016 to October 2021 from the China Osteonecrosis of the Femoral Head Database (CONFHD). The patients with ONFH, and unilateral hip affected at the first visit were divided into THA group and non-THA group according to if they had undergone THA treatment. The differences between the two groups of patients in terms of gender, age at the time of consultation, body mass index (BMI), etiology, onset side, association research circulation osseous (ARCO) stage, hip joint function, visual analog scale (VAS), etc. were analyzed. Multivariate binomial logistic regression analysis was then applied to evaluate the risk factors of ONFH patients who underwent THA during the first visit.

RESULTS

A total of 640 patients were recruited for analysis, including 209 cases from the THA group and 431 cases from the non-THA group. The results of univariate analysis showed that the two groups of patients were significantly different in the following six indicators: age (59 vs. 46, Z = -9.58, p < 0.001), duration of disease (78 vs. 17, Z = -16.14, p < 0.001), gender composition (χ  = 8.09, p = 0.004), disease etiology (χ  = 33.04, p < 0.001), ARCO stage (χ  = 334.86, p < 0.001), flexion of hip joint (χ  = 172.33, p < 0.001). However, the comparison between the two groups on VAS (Z = -0.82, p = 0.41), BMI (Z = -1.35, p = 0.18), and onset side (χ  = 1.53, p = 0.22) did not obviously differ. The results regression analysis showed that the age at the time of consultation, duration of disease, ARCO stage, and the hip joint function affected the decision making if the patients should undergo THA. The results of receiver operating characteristic curve (ROC) analysis showed that aforementioned indicators were satisfactory in predicting whether patients with ONFH would be treated with THA. The regression model using the above four indicators as comprehensive indicators has satisfactory performance in predicting whether to perform THA, and the area under the curve (AUC) is 93.94%.

CONCLUSION

These factors such as age, duration of disease, ARCO stage, and hip flexion function should be considered comprehensively before making decisions to perform THA or not in our clinical practice.

摘要

目的

目前对于股骨头坏死(ONFH)患者接受髋关节置换术(THA)治疗的适应证尚无共识或指导意见。本研究旨在探讨影响 ONFH 患者接受 THA 决策的因素,为临床决策提供参考,以帮助 ONFH 患者决定是否进行 THA 或保髋治疗。

方法

本回顾性病例对照研究纳入了 2016 年 7 月至 2021 年 10 月期间中国股骨头坏死数据库(CONFHD)的 ONFH 患者数据。根据是否接受 THA 治疗,将首次就诊时单侧髋关节受累的 ONFH 患者分为 THA 组和非 THA 组。分析两组患者的性别、就诊时年龄、体质量指数(BMI)、病因、发病侧别、关联研究循环骨质(ARCO)分期、髋关节功能、视觉模拟评分(VAS)等方面的差异。然后应用多变量二项逻辑回归分析评估首次就诊时接受 THA 的 ONFH 患者的危险因素。

结果

共纳入 640 例患者进行分析,其中 THA 组 209 例,非 THA 组 431 例。单因素分析结果显示,两组患者在以下 6 个指标上差异有统计学意义:年龄(59 岁比 46 岁,Z=-9.58,p<0.001)、病程(78 个月比 17 个月,Z=-16.14,p<0.001)、性别构成(χ ²=8.09,p=0.004)、病因(χ ²=33.04,p<0.001)、ARCO 分期(χ ²=334.86,p<0.001)、髋关节屈曲(χ ²=172.33,p<0.001)。然而,两组间 VAS(Z=-0.82,p=0.41)、BMI(Z=-1.35,p=0.18)和发病侧别(χ ²=1.53,p=0.22)比较差异无统计学意义。回归分析结果显示,就诊时年龄、病程、ARCO 分期和髋关节功能影响患者是否接受 THA 的决策。受试者工作特征曲线(ROC)分析结果表明,上述指标预测 ONFH 患者是否接受 THA 的效果良好。使用上述四个指标作为综合指标的回归模型在预测是否行 THA 方面具有良好的性能,曲线下面积(AUC)为 93.94%。

结论

在临床实践中,应综合考虑年龄、病程、ARCO 分期和髋关节屈曲功能等因素,以决定是否行 THA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/1cce60e44df5/OS-15-731-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/f0804d33c2f7/OS-15-731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/460e31834d2e/OS-15-731-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/efd50e2dc67e/OS-15-731-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/1cce60e44df5/OS-15-731-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/f0804d33c2f7/OS-15-731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/460e31834d2e/OS-15-731-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/efd50e2dc67e/OS-15-731-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/9977578/1cce60e44df5/OS-15-731-g005.jpg

相似文献

1
Hip Preservation or Total Hip Arthroplasty? A Retrospective Case-Control Study of Factors Influencing Arthroplasty Decision-Making for Patients with Osteonecrosis of the Femoral Head in China.髋关节保髋治疗还是全髋关节置换术?一项在中国影响股骨头坏死患者行关节置换术决策因素的回顾性病例对照研究。
Orthop Surg. 2023 Mar;15(3):731-739. doi: 10.1111/os.13639. Epub 2023 Jan 10.
2
Comparison of Outcomes Following Total Hip Arthroplasty Between Patients Diagnosed with Association Research Circulation Osseous (ARCO) Stage III and Stage IV Osteonecrosis of the Femoral Head: A Retrospective Study of 302 Patients.比较 Association Research Circulation Osseous(ARCO)III 期和 IV 期股骨头坏死患者全髋关节置换术后结局:302 例患者的回顾性研究。
Med Sci Monit. 2023 Jan 17;29:e938991. doi: 10.12659/MSM.938991.
3
One-sided hip-preserving and concurrent contralateral total hip arthroplasty for the treatment of bilateral osteonecrosis of the femoral head in different stages: short-medium term outcomes.一期保髋与同期对侧全髋关节置换术治疗不同阶段双侧股骨头坏死:中短期疗效
BMC Musculoskelet Disord. 2015 Jun 5;16:133. doi: 10.1186/s12891-015-0583-5.
4
[EFFECTIVENESS OF BONE GRAFTING THROUGH WINDOWING AT FEMORAL HEAD-NECK JUNCTION FOR TREATMENT OF OSTEONECROSIS WITH SEGMENTAL COLLAPSE OF FEMORAL HEAD].经股骨头颈交界处开窗植骨治疗股骨头节段性塌陷型骨坏死的疗效观察
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2016 Apr;30(4):397-401.
5
Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression.骨髓间充质干细胞移植治疗股骨头坏死的临床疗效:与单纯髓芯减压的配对对照研究。
Stem Cell Res Ther. 2018 Oct 25;9(1):274. doi: 10.1186/s13287-018-1030-y.
6
Primary stability of calcar-guided short-stem total hip arthroplasty in the treatment of osteonecrosis of the femoral head: migration analysis using EBRA-FCA.EBRA-FCA 测量下的皮质骨导向短柄全髋关节置换治疗股骨头坏死的初始稳定性:迁移分析
Arch Orthop Trauma Surg. 2020 Dec;140(12):2091-2100. doi: 10.1007/s00402-020-03610-4. Epub 2020 Oct 4.
7
Long-term outcomes of Phemister bone grafting for patients with non-traumatic osteonecrosis of the femoral head.Phemister 骨移植治疗非创伤性股骨头坏死患者的长期疗效。
Int Orthop. 2019 Mar;43(3):579-587. doi: 10.1007/s00264-018-4013-9. Epub 2018 Jun 18.
8
Surgical hip dislocation technique through the femoral head fovea fenestration and impaction bone grafting for the treatment of non-traumatic osteonecrosis of the femoral head: a retrospective study.经股骨头凹开窗术和打压植骨治疗非创伤性股骨头坏死的髋关节脱位技术:一项回顾性研究。
J Orthop Surg Res. 2024 Jul 26;19(1):437. doi: 10.1186/s13018-024-04901-x.
9
Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial.成骨细胞疗法是否改善了股骨颈骨折前骨坏死的预后?一项随机对照试验。
Clin Orthop Relat Res. 2020 Jun;478(6):1307-1315. doi: 10.1097/CORR.0000000000001107.
10
Porous tantalum rod implantation is associated with low survival rates in patients with type C2 osteonecrosis of the femoral head but has no effect on the clinical outcome of conversion total hip arthroplasty: a retrospective study with an average 8-year follow-up.多孔钽棒植入与 C2 型股骨头坏死患者的低生存率相关,但对转换全髋关节置换术的临床结果无影响:一项平均 8 年随访的回顾性研究。
BMC Musculoskelet Disord. 2020 Dec 12;21(1):841. doi: 10.1186/s12891-020-03860-8.

引用本文的文献

1
Arthroscopic Core Decompression With Allogeneic Bone Grafting for Femoral Head Osteonecrosis and Femoral Head-Neck Junction Cysts.关节镜下异体骨移植核心减压治疗股骨头坏死及股骨头-颈交界区囊肿
Arthrosc Tech. 2024 Dec 28;14(5):103397. doi: 10.1016/j.eats.2024.103397. eCollection 2025 May.
2
Comparison of outcomes after total hip arthroplasty between patients with osteonecrosis of the femoral head in Association Research Circulation Osseous stage III and stage IV: a five-year follow-up study.股骨头坏死 Association Research Circulation Osseous 分期 III 期和 IV 期患者全髋关节置换术后结局的比较:一项为期五年的随访研究。
J Orthop Surg Res. 2024 Mar 6;19(1):170. doi: 10.1186/s13018-024-04617-y.

本文引用的文献

1
Effect of porosity of a functionally-graded scaffold for the treatment of corticosteroid-associated osteonecrosis of the femoral head in rabbits.功能梯度支架孔隙率对兔激素性股骨头坏死治疗效果的影响
J Orthop Translat. 2021 Mar 16;28:90-99. doi: 10.1016/j.jot.2021.01.002. eCollection 2021 May.
2
Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model.唑来膦酸局部给药可预防大鼠模型中的股骨头创伤性骨坏死。
J Orthop Translat. 2021 Mar 8;27:132-138. doi: 10.1016/j.jot.2020.08.005. eCollection 2021 Mar.
3
Urinary miRNAs as biomarkers for idiopathic osteonecrosis of femoral head: A multicentre study.
尿微小RNA作为股骨头缺血性坏死的生物标志物:一项多中心研究。
J Orthop Translat. 2020 Feb 21;26:54-59. doi: 10.1016/j.jot.2020.01.008. eCollection 2021 Jan.
4
Epidemiological Study Based on China Osteonecrosis of the Femoral Head Database.基于中国股骨头坏死数据库的流行病学研究。
Orthop Surg. 2021 Feb;13(1):153-160. doi: 10.1111/os.12857. Epub 2020 Dec 21.
5
Current Treatment Modalities for Osteonecrosis of Femoral Head in Mainland China: A Cross-Sectional Study.中国大陆股骨头坏死的当前治疗方式:一项横断面研究。
Orthop Surg. 2020 Dec;12(6):1776-1783. doi: 10.1111/os.12810. Epub 2020 Oct 15.
6
Exploring the Risk Factors for the Misdiagnosis of Osteonecrosis of Femoral Head: A Case-Control Study.探讨股骨头坏死误诊的危险因素:一项病例对照研究。
Orthop Surg. 2020 Dec;12(6):1792-1798. doi: 10.1111/os.12821. Epub 2020 Oct 16.
7
Management of osteonecrosis of the femoral head.股骨头坏死的治疗。
Bone Joint J. 2020 Jul;102-B(7_Supple_B):122-128. doi: 10.1302/0301-620X.102B7.BJJ-2019-1611.R1.
8
Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).成人股骨头坏死临床诊疗指南(2019年版)
J Orthop Translat. 2020 Jan 6;21:100-110. doi: 10.1016/j.jot.2019.12.004. eCollection 2020 Mar.
9
Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head: A 14-year follow-up of convalescent SARS patients.治疗类固醇相关股骨头坏死的中药活骨方:对康复期非典患者的14年随访
J Orthop Translat. 2020 Apr 4;23:122-131. doi: 10.1016/j.jot.2020.03.014. eCollection 2020 Jul.
10
Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.非创伤性股骨头坏死:今天我们站在哪里?:5 年更新。
J Bone Joint Surg Am. 2020 Jun 17;102(12):1084-1099. doi: 10.2106/JBJS.19.01271.